MedTrace Logo

PREdiabetes GLycemic Impact and Data Evaluation

NCT07599072 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-05-20

No results posted yet for this study

Summary

This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.

Conditions

Interventions

DEVICE

CGM Sibionics

A registered medical device for real-time monitoring of glucose levels in interstitial fluid.

DEVICE

On-Call Extra Glucometer

Capillary glucose monitoring using fingerstick glucometer as per standard care.

Sponsors & Collaborators

  • COR-Medical LLC

    collaborator UNKNOWN

  • Iridium LLC

    collaborator UNKNOWN

  • Nazarii Kobyliak

    lead OTHER

Principal Investigators

  • Nazarii Kobyliak · Bogomolets National Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2026-12-31
Completion
2027-01-31

Countries

  • Ukraine

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07599072 on ClinicalTrials.gov